Zobrazeno 1 - 10
of 23
pro vyhledávání: ''
Autor:
Masakazu Hashimoto, Hiroshi Aikata, Tsuyoshi Kobayashi, Kazuaki Chayama, Shintaro Kuroda, Tomokazu Kawaoka, Masateru Yamamoto, Hideki Ohdan
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Cancer
BMC Cancer
Background Patients diagnosed with Barcelona Clinic Liver Cancer (BCLC) intermediate stage hepatocellular carcinoma (HCC) encompass a broad clinical population. Kinki criteria subclassifications have been proposed to better predict prognoses and dete
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Cancer
BMC Cancer
BackgroundThe purpose of this retrospective study was to evaluate the survival outcomes of pembrolizumab (PEM) plus enzalutamide (ENZ) versus PEM alone in selected populations of men with previously untreated metastatic castration-resistant prostate
Autor:
Mai Iwaya, Takehito Ehara, Tomoyuki Nakajima, Hiroyoshi Ota, Takeshi Uehara, Shota Kobayashi, Yasuhiro Kinugawa, Yuji Soejima
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-6 (2021)
BMC Cancer
BMC Cancer
Background Leucine-rich repeat-containing G-protein-coupled receptor 5 (LGR5) is an important cancer stem cell marker in gastric cancer. However, no detailed studies are available on LGR5 expression in poorly differentiated gastric adenocarcinoma (PD
Autor:
Kohei Taniguchi, Kazumasa Komura, Tomohito Tanaka, Hirofumi Uehara, Yoshio Ohno, Haruhito Azuma, Koichiro Minami, Kiyoshi Takahara, Teruo Inamoto, Takeshi Tsutsumi, Takeshi Hashimoto, Naoya Satake, Yuki Yoshikawa, Takuya Tsujino, Hayahito Nomi, Ryu Muraoka, Tomoaki Takai, Naokazu Ibuki, Tomohisa Matsunaga, Hajime Hirano
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Cancer
BMC Cancer
Background We assessed the prognostic value of body mass index (BMI) in Asian patients with localized RCC who underwent nephrectomy. Methods A total of 665 patients who underwent nephrectomy for localized RCC were enrolled in the present study and di
Autor:
Yuankai Shi, Jianqiu Wu, Zhen Wang, Liling Zhang, Zhao Wang, Mingzhi Zhang, Hong Cen, Zhigang Peng, Yufu Li, Lei Fan, Ye Guo, Liping Ma, Jie Cui, Yuhuan Gao, Haiyan Yang, Hongyu Zhang, Lin Wang, Weihua Zhang, Huilai Zhang, Liping Xie, Ming Jiang, Hui Zhou, Yuerong Shuang, Hang Su, Xiaoyan Ke, Chuan Jin, Xin Du, Li Liu, Yaming Xi, Zheng Ge, Ru Feng, Yang Zhang, Shengyu Zhou, Fan Xie, Qian Wang
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-13 (2021)
Journal of Hematology & Oncology
Journal of Hematology & Oncology
Background Peripheral T cell lymphoma (PTCL) is a rare disease and recent approved drugs for relapsed/refractory (r/r) PTCL provided limited clinical benefit. We conducted this study to evaluate the efficacy and safety of geptanolimab (GB226), an ant
Autor:
Shahzad Riyaz, Abu Bakar Hafeez Bhatti, Nusrat Yar Khan, Atif Rana, Faisal Saud Dar, Haseeb Haider Zia, Rizmi Tahir, Ammal Imran Qureshi
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
BMC Cancer
BMC Cancer
BackgroundLiving donor liver transplantation (LDLT) is an acceptable treatment option for hepatocellular carcinoma (HCC). Traditional transplant criteria aim at best utilization of donor organs with low risk of post transplant recurrence. In LDLT, lo
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
BMC Cancer
BMC Cancer
Background Addition of oxaliplatin to capecitabine remains controversial for locally advanced rectal cancer (LARC). And cumulative oxaliplatin dose (COD) varied among clinical trials showing different therapeutic effects of this regimen. The objectiv
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
BMC Cancer
BMC Cancer
Background Liver fibrosis or cirrhosis is associated with the dismal prognosis of hepatocellular carcinoma (HCC), and it might also be involved in intrahepatic cholangiocarcinoma (ICC). The effect of hepatic fibrosis on the survival of ICC patients i
Autor:
Yi-Hung Kuo, Wen-Shih Huang, Yun-Ching Huang, Chih-Jung Chen, Chih-Chien Chin, Chia-Hsuan Lai, Cheng-Yi Huang
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-11 (2019)
BMC Cancer
BMC Cancer
Background Current advancements in neoadjuvant therapy and total mesorectal excision have engendered increased local control. However, the survival benefit of preoperative radiotherapy (RT; 5 × 5 Gy) in rectal cancer patients remains inadequate, pri
Autor:
Linfang Li, Hao Chen, Su-Yin He, Miantao Wu, Shulin Chen, Zheng-Qiang He, Yuan-Ying Zhu, Xia He
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-11 (2019)
BMC Cancer
BMC Cancer
Background Despite recent advances in the treatments of hepatocellular carcinoma (HCC), the prognosis of HCC patients remains controversial. The purpose of this study was to investigate the prognostic performance of pretreatment albumin to C-reactive